APOA2 Antikörper (AA 28-56)
(2 Referenzen)-
- Target Alle APOA2 Antikörper anzeigen
- APOA2 (Apolipoprotein A-II (APOA2))
-
Bindungsspezifität
- AA 28-56
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser APOA2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Homologie
- Pr
- Aufreinigung
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
- Immunogen
- This APOA2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 28-56 amino acids from the Central region of human APOA2.
- Klon
- RB15149
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product APOA2 Primärantikörper
-
anti-Apolipoprotein A-II (APOA2) (AA 1-100) antibody
APOA2 Reaktivität: Human WB, ELISA, IHC (p), IF Wirt: Maus Monoclonal 1H6 unconjugated
anti-Apolipoprotein A-II (APOA2) (AA 24-100) antibodyAPOA2 Reaktivität: Human WB, ELISA, IHC (p), ICC, IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-II (APOA2) (AA 24-100) antibodyAPOA2 Reaktivität: Human, Ratte ELISA, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-II (APOA2) antibodyAPOA2 Reaktivität: Human WB, ELISA, IHC, FACS Wirt: Kaninchen Monoclonal 6H2 unconjugated Recombinant Antibody
anti-Apolipoprotein A-II (APOA2) (AA 1-100) antibodyAPOA2 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-II (APOA2) (AA 24-102) antibodyAPOA2 Reaktivität: Ratte WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-II (APOA2) (AA 1-101) antibodyAPOA2 Reaktivität: Human WB, IHC (p), EIA Wirt: Maus Monoclonal 1H6 unconjugated
anti-Apolipoprotein A-II (APOA2) (AA 23-56) antibodyAPOA2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Apolipoprotein A-II (APOA2) (AA 1-100) antibodyAPOA2 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Apolipoprotein A-II (APOA2) (N-Term) antibodyAPOA2 Reaktivität: Human, Ratte, Schwein, Maus, Hund, Meerschweinchen, Pferd WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- WB: 1:1000. IHC-P: 1:10~50
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Haltbarkeit
- 6 months
-
-
: "Evaluating the association of common APOA2 variants with type 2 diabetes." in: BMC medical genetics, Vol. 10, pp. 13, (2009) (PubMed).
: "Procoagulant activities of plasma factor VIIc and factor Xc are positively and independently associated with concentrations of the high-density lipoprotein apolipoprotein, apo A-II." in: Thrombosis and haemostasis, Vol. 100, Issue 3, pp. 391-6, (2008) (PubMed).
-
: "Evaluating the association of common APOA2 variants with type 2 diabetes." in: BMC medical genetics, Vol. 10, pp. 13, (2009) (PubMed).
-
- Target
- APOA2 (Apolipoprotein A-II (APOA2))
- Andere Bezeichnung
- APOA2 (APOA2 Produkte)
- Hintergrund
- APOA2, apolipoprotein (apo-) A-II, which is the second most abundant protein of the high density lipoprotein particles. The protein is found in plasma as a monomer, homodimer, or heterodimer with apolipoprotein D. Defects in this gene may result in apolipoprotein A-II deficiency or hypercholesterolemia.
- Molekulargewicht
- 11175
- NCBI Accession
- NP_001634
- UniProt
- P02652
- Pathways
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism
-
